快猫短视频

#118: Heatwaves push limits of human tolerance; chemical computer to mimic brain; first non-human to practice medicine

About this episode

It feels like temperature records are being broken almost daily. We鈥檝e seen heatwaves already this year in Texas and Mexico, with forecast highs of 50oC set to hit Pakistan and India. As we edge closer to breaking 1.5 degrees of global warming in the next 5 years, Rowan speaks to climate scientist Vikki Thompson from the University of Bristol, to find out how heatwaves are pushing at the limits of what humans can cope with.

Chemical computers have taken a step up. Lee Cronin and his colleagues at the University of Glasgow have upgraded their 2019 machine, and it鈥檚 now fully programmable. The team discusses the project鈥檚 ultimate goal, to make a chemical brain and even explain consciousness.

Ants have the power to heal. The team explains how Matabele ants, large ants found in sub-Saharan Africa, have evolved the ability to diagnose infected wounds in their nestmates using an antimicrobial medicine that they produce themselves.

It鈥檚 estimated that covid-19 has now killed close to 15 million people. And with reports of rapid reinfections and new omicron sublineages emerging, the team finds out how worried we should be about getting covid multiple times, and what we can expect from future mutations of the virus.

The composer Jon Hopkins has been working with a team involving neuroscientist Anil Seth to create a hallucinogenic immersive experience called Dream Machine. 快猫短视频鈥檚 Carissa Wong has been in it, and shares her wild experience. We also treat you to the music from Dream Machine throughout this episode.

On the pod are , Penny Sarchet, Alice Klein, Karmela Padavic-Callaghan and Carissa Wong. To read about these stories and much more, subscribe at newscientist.com/podcasts.

Events and discount codes:

newscientist.com/pod20

newscientist.com/unlimited

newscientist.com/nslive

newscientist.com/tours

Hosted on Acast. See for more information.

Learn more about your ad choices. Visit